Saturday, 14 March 2015 09:58

Anticoagulation news items. Week commencing 9th March 2015

Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines

British Medical Journal

This research finds guideline recommendations often don't consider potential drug-drug or -disease interactions that may be present if patients have co-morbidities. The authors call for guideline developers to more explicitly account for multimorbidity in their recommendations.

 

Revised SPC: Plavix™ (clopidogrel) tablets

Annals of Emergency Medicine

Section 4.8 has been updated to include two new undesirable effects - acute generalised exanthematous pustulosis (very rare) and gynaecomastia (rare).

 

Apixaban (Eliquis)

Scottish Medicines Consortium

The SMC has accepted apixaban (Eliquis) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults.

 

 

The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at:

http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services